- Report
- October 2023
- 81 Pages
Canada
From €3077EUR$3,500USD£2,683GBP
- Report
- January 2023
- 44 Pages
Global
From €1319EUR$1,500USD£1,150GBP
- Report
- May 2024
- 50 Pages
United States
€9731EUR$11,457USD£8,200GBP
- Report
- October 2025
- 99 Pages
Italy
From €4263EUR$4,850USD£3,718GBP
- Report
- October 2025
- 98 Pages
South Korea
From €4263EUR$4,850USD£3,718GBP
- Report
- September 2025
- 87 Pages
Qatar
From €4263EUR$4,850USD£3,718GBP
- Report
- June 2023
- 62 Pages
Global
From €1714EUR$1,950USD£1,495GBP
- Report
- February 2018
- 135 Pages
Global
From €4395EUR$5,000USD£3,833GBP
- Report
- January 2018
- 59 Pages
Global
From €2633EUR$2,995USD£2,296GBP
The Pricing and Reimbursement market within the Pharmaceuticals industry is a complex system of pricing and reimbursement policies that determine the cost of drugs and the amount of money that is reimbursed to patients. It is a highly regulated market, with governments and other organizations setting the prices of drugs and the amount of reimbursement that is available. The market is also influenced by the availability of generic drugs, which can often be cheaper than brand-name drugs. Additionally, the market is affected by the availability of health insurance, which can affect the amount of reimbursement that is available.
Companies in the Pricing and Reimbursement market include pharmaceutical companies, health insurance providers, government agencies, and third-party payers. These companies are responsible for setting prices, negotiating reimbursement rates, and ensuring that patients have access to the drugs they need. Show Less Read more